UBS Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-87,639
| Closed | -$585K | – | 8953 |
|
|
2023
Q3 | $585K | Buy |
87,639
+24,463
| +39% | +$163K | ﹤0.01% | 3498 |
|
|
2023
Q2 | $572K | Buy |
63,176
+29,894
| +90% | +$271K | ﹤0.01% | 3717 |
|
|
2023
Q1 | $242K | Sell |
33,282
-67,475
| -67% | -$491K | ﹤0.01% | 4214 |
|
|
2022
Q4 | $735K | Buy |
100,757
+74,704
| +287% | +$545K | ﹤0.01% | 3381 |
|
|
2022
Q3 | $201K | Buy |
26,053
+14,719
| +130% | +$114K | ﹤0.01% | 4054 |
|
|
2022
Q2 | $77K | Buy |
+11,334
| New | +$77K | ﹤0.01% | 4617 |
|
|
2022
Q1 | – | Sell |
-2,455
| Closed | -$14K | – | 9858 |
|
|
2021
Q4 | $14K | Buy |
+2,455
| New | +$14K | ﹤0.01% | 7257 |
|
|
2021
Q3 | – | Sell |
-509
| Closed | -$5K | – | 8977 |
|
|
2021
Q2 | $5K | Sell |
509
-4,016
| -89% | -$39.5K | ﹤0.01% | 7485 |
|
|
2021
Q1 | $48K | Buy |
4,525
+3,577
| +377% | +$37.9K | ﹤0.01% | 5598 |
|
|
2020
Q4 | $13K | Buy |
+948
| New | +$13K | ﹤0.01% | 6278 |
|